These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12014043)

  • 1. [Knowledge about PSA among primary care physicians].
    Chesa Ponce N; Orengo Valverde JC
    Arch Esp Urol; 2002 Mar; 55(2):113-6. PubMed ID: 12014043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
    Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
    Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
    Dyche DJ; Ness J; West M; Allareddy V; Konety BR
    J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of postgraduate education on COPD knowledge level of primary care physicians].
    Başyiğit I; Yildiz F; Başoğul A; Boyaci H; Ilgazli A
    Tuberk Toraks; 2006; 54(1):51-5. PubMed ID: 16615018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidance of anticipated regret: the ordering of prostate-specific antigen tests.
    Sorum PC; Mullet E; Shim J; Bonnin-Scaon S; Chasseigne G; Cogneau J
    Med Decis Making; 2004; 24(2):149-59. PubMed ID: 15090101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of prostate cancer screening among health fair participants.
    Chiu BC; Anderson JR; Corbin D
    Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
    BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prostate-specific antigen as a predictor of prostate volume in the community: the Krimpen study.
    Bohnen AM; Groeneveld FP; Bosch JL
    Eur Urol; 2007 Jun; 51(6):1645-52; discussion 1652-3. PubMed ID: 17320271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national survey of medical students' beliefs and knowledge in screening for prostate cancer.
    Marcella S; Delnevo CD; Coughlin SS
    J Gen Intern Med; 2007 Jan; 22(1):80-5. PubMed ID: 17351844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological diagnosis of prostate cancer in Korean men aged 70-79 years.
    Shim HB; Lee SE; Park HK; Ku JH
    Jpn J Clin Oncol; 2007 Oct; 37(10):782-7. PubMed ID: 17913831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision making in prostate-specific antigen screening National Health Interview Survey, 2000.
    Han PK; Coates RJ; Uhler RJ; Breen N
    Am J Prev Med; 2006 May; 30(5):394-404. PubMed ID: 16627127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ; Mangold LA; Epstein JI; Partin AW
    Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
    Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
    Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
    Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
    BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.